KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Astrana Health (ASTH) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Astrana Health (ASTH) over the last 17 years, with Q3 2025 value amounting to $858.9 million.

  • Astrana Health's Cost of Revenue rose 11194.91% to $858.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 billion, marking a year-over-year increase of 7774.54%. This contributed to the annual value of $1.8 billion for FY2024, which is 5047.77% up from last year.
  • Astrana Health's Cost of Revenue amounted to $858.9 million in Q3 2025, which was up 11194.91% from $576.8 million recorded in Q2 2025.
  • In the past 5 years, Astrana Health's Cost of Revenue ranged from a high of $858.9 million in Q3 2025 and a low of $136.2 million during Q2 2021
  • Its 5-year average for Cost of Revenue is $340.0 million, with a median of $289.4 million in 2023.
  • Its Cost of Revenue has fluctuated over the past 5 years, first crashed by 248.81% in 2021, then skyrocketed by 11194.91% in 2025.
  • Astrana Health's Cost of Revenue (Quarter) stood at $171.8 million in 2021, then soared by 47.3% to $253.1 million in 2022, then rose by 24.07% to $314.1 million in 2023, then surged by 95.74% to $614.7 million in 2024, then surged by 39.71% to $858.9 million in 2025.
  • Its Cost of Revenue stands at $858.9 million for Q3 2025, versus $576.8 million for Q2 2025 and $549.1 million for Q1 2025.